{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:09:40Z","timestamp":1751342980002,"version":"3.41.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["21CGA27"],"award-info":[{"award-number":["21CGA27"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722413","2022M722417"],"award-info":[{"award-number":["2022M722413","2022M722417"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22YF1436500","23YF1434900"],"award-info":[{"award-number":["22YF1436500","23YF1434900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWYgf2021-01"],"award-info":[{"award-number":["PWYgf2021-01"]}],"id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12265-025-10604-3","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T14:42:08Z","timestamp":1742222528000},"page":"586-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1\/2 Pathway"],"prefix":"10.1007","volume":"18","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5743-8512","authenticated-orcid":false,"given":"Yahan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"10604_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y.","journal-title":"Nat Rev Cardiol"},{"key":"10604_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"TG Martin","year":"2004","unstructured":"Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol. 2004;109:1580\u20139. https:\/\/doi.org\/10.1161\/01.CIR.0000120390.68287.BB.","journal-title":"Nat Rev Cardiol"},{"key":"10604_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109:1580\u20139. https:\/\/doi.org\/10.1161\/01.CIR.0000120390.68287.BB.","journal-title":"Circulation"},{"key":"10604_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30\u201341. https:\/\/doi.org\/10.1038\/nrcardio.2010.165.","journal-title":"Nat Rev Cardiol"},{"key":"10604_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89:1401\u201338. https:\/\/doi.org\/10.1007\/s00204-015-1477-x.","journal-title":"Arch Toxicol"},{"key":"10604_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41401-020-0496-1","volume":"42","author":"BY Liu","year":"2021","unstructured":"Liu BY, Li L, Liu GL, Ding W, Chang WG, Xu T, Ji XY, Zheng XX, Zhang J, Wang JX. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacol Sin. 2021;42:701\u201314. https:\/\/doi.org\/10.1038\/s41401-020-0496-1.","journal-title":"Acta Pharmacol Sin"},{"key":"10604_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","volume":"133","author":"A Shirakabe","year":"2016","unstructured":"Shirakabe A, Zhai P, Ikeda Y, Saito T, Maejima Y, Hsu CP, Nomura M, Egashira K, Levine B, Sadoshima J. Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure. Circulation. 2016;133:1249\u201363. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020502.","journal-title":"Circulation"},{"key":"10604_CR8","doi-asserted-by":"publisher","first-page":"104274","DOI":"10.1016\/j.ebiom.2022.104274","volume":"85","author":"QL Zhou","year":"2022","unstructured":"Zhou QL, Meng D, Li F, Zhang X, Liu L, Zhu YJ, Liu SQ, Xu MJ, Deng JL, Lei ZY, Sluijter JPG, Xiao JJ. Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling. EBioMedicine. 2022;85:104274. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104274.","journal-title":"EBioMedicine"},{"key":"10604_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1172\/JCI38022","volume":"119","author":"HY Ling","year":"2009","unstructured":"Ling HY, Zhang T, Pereira L, Means CK, Cheng HQ, Gu YS, Dalton ND, Peterson KL, Chen J, Bers D, Brown JH. Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest. 2009;119:1230\u201340. https:\/\/doi.org\/10.1172\/JCI38022.","journal-title":"J Clin Invest"},{"key":"10604_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/363637a0","volume":"363","author":"B Fenton","year":"1993","unstructured":"Fenton B, Glover DM. A conserved mitotic kinase active at late anaphase-telophase in syncytial Drosophila embryos. Nature. 1993;363:637\u201340. https:\/\/doi.org\/10.1038\/363637a0.","journal-title":"Nature"},{"key":"10604_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrm3819","volume":"15","author":"S Zitouni","year":"2014","unstructured":"Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014;15:433\u201352. https:\/\/doi.org\/10.1038\/nrm3819.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10604_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrm2653","volume":"10","author":"V Archambault","year":"2009","unstructured":"Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol. 2009;10:265\u201375. https:\/\/doi.org\/10.1038\/nrm2653.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10604_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrm1401","volume":"5","author":"FA Barr","year":"2004","unstructured":"Barr FA, Sillj\u00e9 HH, Nigg EA. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol. 2004;5:429\u201340. https:\/\/doi.org\/10.1038\/nrm1401.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10604_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13238-012-2020-y","volume":"3","author":"J Luo","year":"2012","unstructured":"Luo J, Liu X. Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development, Protein. Cell. 2012;3:182\u201397. https:\/\/doi.org\/10.1007\/s13238-012-2020-y.","journal-title":"Cell"},{"key":"10604_CR15","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1038\/s41467-021-23053-8","volume":"12","author":"W Shi","year":"2021","unstructured":"Shi W, Zhang G, Ma Z, et al. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer. Nat Commun. 2021;12:2812. https:\/\/doi.org\/10.1038\/s41467-021-23053-8.","journal-title":"Nat Commun"},{"key":"10604_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrd3184","volume":"9","author":"K Strebhardt","year":"2010","unstructured":"Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov. 2010;9:643\u201360. https:\/\/doi.org\/10.1038\/nrd3184.","journal-title":"Nat Rev Drug Discov"},{"key":"10604_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-20-1377","volume":"81","author":"L Gheghiani","year":"2021","unstructured":"Gheghiani L, Wang L, Zhang Y, et al. PLK1 induces chromosomal instability and overrides cell-cycle checkpoints to drive tumorigenesis. Cancer Res. 2021;81:1293\u2013307. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1377.","journal-title":"Cancer Res"},{"key":"10604_CR18","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1038\/s41467-020-17697-1","volume":"11","author":"E Montaudon","year":"2020","unstructured":"Montaudon E, Nikitorowicz-Buniak J, Sourd L, et al. PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance. Nat Commun. 2020;11:4053. https:\/\/doi.org\/10.1038\/s41467-020-17697-1.","journal-title":"Nat Commun"},{"key":"10604_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ph15050523","volume":"15","author":"R Chilamakuri","year":"2022","unstructured":"Chilamakuri R, Rouse DC, Agarwal S. Inhibition of polo-like kinase 1 by HMN-214 blocks cell cycle progression and inhibits neuroblastoma growth. Pharmaceuticals (Basel). 2022;15:523. https:\/\/doi.org\/10.3390\/ph15050523.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10604_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12931-015-0257-8","volume":"16","author":"S Jiang","year":"2015","unstructured":"Jiang S, Tang DD. Plk1 regulates MEK1\/2 and proliferation in airway smooth muscle cells. Respir Res. 2015;16(1):93. https:\/\/doi.org\/10.1186\/s12931-015-0257-8.","journal-title":"Respir Res"},{"key":"10604_CR21","doi-asserted-by":"publisher","unstructured":"Luo Y, Jiang N, May HI, Luo X, Ferdous A, Schiattarella GG, \u2026 Hill JA. Cooperative binding of ETS2 and NFAT Links Erk1\/2 and calcineurin signaling in the pathogenesis of cardiac hypertrophy. Circulation. 2021;144(1):34\u201351. https:\/\/doi.org\/10.1161\/circulationaha.120.052384.","DOI":"10.1161\/circulationaha.120.052384"},{"key":"10604_CR22","doi-asserted-by":"publisher","first-page":"e202009083","DOI":"10.1083\/jcb.202009083","volume":"220","author":"M Ohta","year":"2021","unstructured":"Ohta M, Zhao ZL, Wu D, Wang SH, Harrison JL, G\u00f3mez-Cavazos JS, Desai A, Oegema KF. Polo-like kinase 1 independently controls microtubule-nucleating capacity and size of the centrosome. J Cell Biol. 2021;220:e202009083. https:\/\/doi.org\/10.1083\/jcb.202009083.","journal-title":"J Cell Biol"},{"key":"10604_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.celrep.2015.06.007","volume":"12","author":"CV Schubert","year":"2015","unstructured":"Schubert CV, Cubizolles F, Bracher JM, Sliedrecht T, Kops GJ, Nigg EA. PLK1 and Mps1 cooperatively regulate the spindle assembly checkpoint in human cells. Cell Rep. 2015;12:66\u201378. https:\/\/doi.org\/10.1016\/j.celrep.2015.06.007.","journal-title":"Cell Rep"},{"key":"10604_CR24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41467-019-10938-y","volume":"10","author":"OA Jones","year":"2019","unstructured":"Jones OA, Tiwari A, Olukoga T, Herbert A. Kok-Lung Chan, PLK1 facilitates chromosome biorientation by suppressing centromere disintegration driven by BLM-mediated unwinding and spindle pulling. Nat Commun. 2019;10:2861. https:\/\/doi.org\/10.1038\/s41467-019-10938-y.","journal-title":"Nat Commun"},{"key":"10604_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06506-6","volume":"621","author":"C Gelot","year":"2023","unstructured":"Gelot C, Kovacs MT, Miron S, et al. Pol\u03b8 is phosphorylated by PLK1 to repair double-strand breaks in mitosis. Nature. 2023;621:415\u201322. https:\/\/doi.org\/10.1038\/s41586-023-06506-6.","journal-title":"Nature"},{"key":"10604_CR26","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-13-2197","volume":"73","author":"BD Cholewa","year":"2013","unstructured":"Cholewa BD, Liu X, Ahmad N. The role of polo-like kinase 1 in carcinogenesis: cause or consequence? Cancer Res. 2013;73:6848\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2197.","journal-title":"Cancer Res"},{"key":"10604_CR27","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1038\/onc.2012.309","volume":"32","author":"A Deeraksa","year":"2013","unstructured":"Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY. PLK1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013;32:2973\u201383. https:\/\/doi.org\/10.1038\/onc.2012.309.","journal-title":"Oncogene"},{"key":"10604_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41417-019-0094-x","volume":"27","author":"Z Gao","year":"2020","unstructured":"Gao Z, Man X, Li Z, et al. PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3. Cancer Gene Ther. 2020;27:412\u201323. https:\/\/doi.org\/10.1038\/s41417-019-0094-x.","journal-title":"Cancer Gene Ther"},{"key":"10604_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/1535-7163.MCT-15-0897","volume":"15","author":"RE Gutteridge","year":"2016","unstructured":"Gutteridge RE, Ndiaye MA, Liu X, Ahmad N. PLK1 inhibitors in cancer therapy: from laboratory to clinics. Mol Cancer Ther. 2016;15:1427\u201335. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0897.","journal-title":"Mol Cancer Ther"},{"key":"10604_CR30","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1158\/1078-0432.CCR-20-2586","volume":"26","author":"AM Zeidan","year":"2020","unstructured":"Zeidan AM, Ridinger M, Lin TL, et al. A Phase Ib study of onvansertib, a novel oral PLK1 Inhibitor, in combination therapy for patients with relapsed or refractory acute myeloid leukemia. Clin Cancer Res. 2020;26:6132\u201340. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2586.","journal-title":"Clin Cancer Res"},{"key":"10604_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/med.21392","volume":"36","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Lardon F, Deschoolmeester V, et al. Spotlight on volasertib: preclinical and clinical evaluation of a promising PLK1 inhibitor. Med Res Rev. 2016;36:749\u201386. https:\/\/doi.org\/10.1002\/med.21392.","journal-title":"Med Res Rev"},{"key":"10604_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","volume":"13","author":"KJ Kurppa","year":"2020","unstructured":"Kurppa KJ, Liu Y, To C, et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell. 2020;13:104-122.e112. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.006.","journal-title":"Cancer Cell"},{"key":"10604_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nature0889964.8","volume":"464","author":"C Jopling","year":"2010","unstructured":"Jopling C, Sleep E, Raya M, Mart\u00ed M, Raya A, Belmonte JCI. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature. 2010;464:606\u20139. https:\/\/doi.org\/10.1038\/nature0889964.8.","journal-title":"Nature"},{"issue":"34","key":"10604_CR34","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1200\/JCO.2008.16.1547","volume":"26","author":"K Mross","year":"2008","unstructured":"Mross K, Frost A, Steinbild S, Hedbom S, Rentschler J, Kaiser R, Rouyrre N, Trommeshauser D, Hoesl CE, Munzert G. Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2008;26(34):5511\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.16.1547.","journal-title":"J Clin Oncol"},{"key":"10604_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.res.0000038488.38975.1a","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, Molkentin JD. Involvement of Extracellular Signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death. Circ Res. 2002;91:776\u201381. https:\/\/doi.org\/10.1161\/01.res.0000038488.38975.1a.","journal-title":"Circ Res"},{"key":"10604_CR36","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M007037200","volume":"275","author":"TL Yue","year":"2000","unstructured":"Yue TL, Gu JL, Wang C, et al. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem. 2000;275:37895\u2013901. https:\/\/doi.org\/10.1074\/jbc.M007037200.","journal-title":"J Biol Chem"},{"key":"10604_CR37","doi-asserted-by":"publisher","first-page":"e10734","DOI":"10.7554\/eLife.10734","volume":"22","author":"JG Wu","year":"2016","unstructured":"Wu JG, Ivanov AI, Fisher PB, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF\/ERK signaling. Elife. 2016;22:e10734. https:\/\/doi.org\/10.7554\/eLife.10734.","journal-title":"Elife"},{"key":"10604_CR38","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.2147\/OTT.S169880","volume":"25","author":"SC Dang","year":"2018","unstructured":"Dang SC, Fan YY, Cui L, Chen JX, Qu JG, Gu M. PLK1 as a potential prognostic marker of gastric cancer through MEK-ERK pathway on PDTX models. Onco Targets Ther. 2018;25:6239\u201347. https:\/\/doi.org\/10.2147\/OTT.S169880.","journal-title":"Onco Targets Ther"},{"key":"10604_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","volume":"131","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella GG, Hill JA. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation. 2015;131:1435\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.013894.","journal-title":"Circulation"},{"key":"10604_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ccell.2019.12.006","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun AA, Badolia R, Lettlova S, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021;33:629\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.006.","journal-title":"Cell Metab"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10604-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:30:07Z","timestamp":1751293807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10604-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10604"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10604-3","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"No human studies were carried out by the authors for this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Studies"}},{"value":"All animal experiments and procedures followed the guidelines for the Care and Use of Laboratory Animals established by the U.S. National Institutes of Health (National Academies Press; 2011) and received approval from Tongji University School of Medicine.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}}]}}